La Roche-Posay Mela B3 Niacinamide Serum, Anti-Aging Dark Spot Corrector
What is Melasyl? Born from 18 years of research, Melasyl is La Roche-Posay’s newest exclusive ingredient designed to visibly reduce a range of skin discolorations, including sun spots, age spots, and post-acne marks. Suitable skin types: The Mela B3 Serum is suitable for all skin types, including sensitive skin. It has been dermatologist- and allergy-tested for safety. For those with sensitive skin, we recommend starting with once-daily application. Fragrance: The Mela B3 Serum uses an allergy-tested formula that contains fragrance. Difference from Glycolic Acid Serum: Mela B3 Serum targets a broad spectrum of skin discolorations—sun, age, and post-acne marks—whereas the Glycolic Acid Serum helps reduce the appearance of dark spots while gradually exfoliating to reveal brighter, more even skin. Expected results: Reduction in the appearance of dark spots was observed starting at 4 weeks (based on a 10-week study of 73 women of various skin phototypes). Key features: - Targeted dark spot remover for the face: Serum that visibly reduces sun spots, age spots, and post-acne marks or post-inflammatory hyperpigmentation for a more even, revitalized complexion. - Promotes radiant, even skin tone: Corrects stubborn dark spots with long-lasting results, revealing brighter, more radiant skin over time. Suitable for women and men. - Breakthrough patented ingredient complex: Formulated with multi-patented Melasyl and a potent 10% niacinamide (Vitamin B3) to effectively target dark spots while respecting natural skin tone. - Clinically proven, dermatologist-backed results: Developed from 18 years of research and proven on all skin tones; 85% of subjects showed significant reduction in persistent dark spots after 8 weeks of consistent use. - Ideal for all skin tones and types: Designed to correct and help prevent persistent dark spots across all skin phototypes while preserving a natural skin tone. Product dimensions: 1. 4 x 2. 17 x 4. 29 inches; 1. 06 ounces.
